GlassScriptPhysician profile
Lauren Copp
NPI 1720328248
$7,550.24
in general payments reported to CMS, 2019-2025
31 companies · $946 in 2025
The $946 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $199 · 2022: $1,357 · 2023: $2,729 · 2024: $2,320 · 2025: $946.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,796 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,795.92 |
| Education | $198.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,747.28 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $863.13 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $634.27 | 2022-2025 | Sotyktu |
| Genzyme Corporation | $486.37 | 2022-2025 | |
| Janssen Biotech, INC. | $425.82 | 2022-2025 | Tremfya, Simponi, Stelara |
| Pfizer INC. | $420.70 | 2021-2024 | |
| Incyte Corporation | $371.40 | 2022-2024 | Opzelura |
| Lilly USA, LLC | $364.03 | 2022-2025 | Taltz, Olumiant, Ebglyss |
| Regeneron Healthcare Solutions, INC. | $268.36 | 2021-2025 | Dupixent |
| Inari Medical, INC. | $226.49 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Ucb, INC. | $200.85 | 2023-2025 | Bimzelx, Cimzia |
| Sun Pharmaceutical Industries INC. | $195.06 | 2022-2025 | Winlevi, Absorica Ld, Blu-U |
| Leo Pharma INC. | $193.51 | 2022-2025 | Adbry |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $185.90 | 2023-2024 | Arazlo, Duobrii, Siliq |
| Arcutis Biotherapeutics, INC. | $178.24 | 2023-2024 | Zoryve |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $173.87 | 2022-2025 | Otezla, Otezla |
| Dermavant Sciences, INC. | $118.54 | 2023-2024 | Vtama |
| Genentech USA, INC. | $102.64 | 2022-2023 | Xolair |
| Mayne Pharma Commercial LLC | $97.02 | 2022-2023 | |
| Galderma Laboratories, L.P. | $47.79 | 2023-2025 | Nemluvio, Epsolay |
| Verrica Pharmaceuticals INC. | $46.61 | 2024 | Ycanth |
| Mallinckrodt Hospital Products INC. | $26.80 | 2024 | Acthar |
| Convatec INC. | $21.53 | 2024 | |
| Fresenius Kabi USA, LLC | $21.52 | 2024 | Idacio |
| Merck Sharp & Dohme LLC | $20.91 | 2023 | Keytruda |
| Medimetriks Pharmaceuticals, INC. | $19.44 | 2025 | |
| Organon LLC | $19.44 | 2025 | Vtama |
| Ani Pharmaceuticals, INC. | $19.39 | 2023 | Apexicon E |
| Almirall LLC | $18.84 | 2023 | Seysara |
| Journey Medical Corporation | $18.03 | 2022 | |
| Biofrontera INC. | $16.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Copp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.